Cynata Therapeutics Limited

A$0.01As of Sun 8 Nov 2026, 12:00 UTC
ASX:CYPHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (32.50%)
Div yield —
ROE (340.78%)
Biotechnology
Beta (5Y) 1.07
PE TTM —
TSR TTM (94.99%)
Mkt cap A$2.921M
ROIC (183.61%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0118
(1.44%)
(37.78%)
Hold 1|12|11|5|10
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
20.72%
15.94%
10.03%
9.89%
Revenue$M
0.210
0.220
0.223
0.231
12.35%
11.73%
14.87%
16.38%
Peers (US$2.006M)
Cap (US$)
PE
2.990M
2.491x
1.936M
—
Capital
TTM
5Y
10Y
Leveragex
0.396
0.080
0.060
EBIT/Intx
0.771
0.276
0.266
Own earn%
40.94
(89.07)
(98.50)
Sh yield%
41.04
21.88
21.61
Owners
Insiders/Inst%
5.57
41.22
Short interest%
4.46
SBC / revenue%
3.47
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
18–23
$1 testx
0.2
Incr. ROIC%
30